Risk of hiv after protected sex
"HIV transmission" AND "condom" AND "risk"
| Sex Act | Risk per 10,000 exposures |
|---|---|
| Receptive anal intercourse | 138 |
| Insertive anal intercourse | 11 |
| Receptive vaginal intercourse | 8 |
| Insertive vaginal intercourse | 4 |
| Receptive fellatio | Low (not zero) |
| Insertive fellatio | Very low |
— Swanson's Family Medicine Review; Harrison's Principles of Internal Medicine 22E (2025)
| Strategy | Estimated Benefit |
|---|---|
| PrEP (emtricitabine + tenofovir, taken daily or on-demand) | ~99% effective with high adherence |
| Long-acting injectable PrEP (cabotegravir every 2 months) | Similar or better efficacy |
| Undetectable viral load in HIV+ partner ("U=U") | Transmission does not occur — 0 transmissions across >125,000 sex acts in clinical studies |
| ART initiated early in HIV+ partner | 96% reduction (HPTN 052 trial) |
Sources: Harrison's Principles of Internal Medicine 22E (2025); Swanson's Family Medicine Review; Goldman-Cecil Medicine